Quaker Houghton reported second-quarter 2026 results with net sales of $532.6 million, up 10% year‑over‑year, and net income of $26.8 million (diluted EPS $1.55). On a non‑GAAP basis the company posted non‑GAAP net income of $37.9 million and non‑GAAP diluted EPS of $2.19; adjusted EBITDA was $85.2 million. Management cited volume-driven growth from new business wins across all regions and announced a $250 million share repurchase program.

Financial Highlights

  • Net sales: $532.6 million for Q2 2026, a 10% increase versus Q2 2025 ($483.4 million).
  • Gross profit: $189.2 million for Q2 2026; reported gross margin 35.5% (non‑GAAP gross profit also $189.2 million, non‑GAAP gross margin 35.5%).
  • Operating income: $40.6 million for Q2 2026 (compared to a loss of $52.5 million in Q2 2025).
  • Net income attributable to Quaker Houghton: $26.8 million for Q2 2026; GAAP diluted EPS $1.55.
  • Non‑GAAP results: non‑GAAP net income $37.9 million and non‑GAAP diluted EPS $2.19; adjusted EBITDA $85.2 million (adjusted EBITDA margin 16.0%).

Business Highlights

  • Volume-driven growth: Sales volumes rose 7% year‑over‑year, driven primarily by net new business wins across all segments and regions.
  • Regional performance: All three reportable segments grew sales versus prior year—Americas up 7%, EMEA up 13%, Asia/Pacific up 12%—with total segment operating earnings improving to $126.5 million.
  • Pricing and mix: Selling price and product mix contributed to sales growth and reflected pricing actions to offset raw material inflation and index‑based contract impacts.
  • Supply resilience: Management highlighted maintained reliable supply despite geopolitical volatility (noting Strait of Hormuz-related pre-buy activity early in the quarter) and saw demand remain steady.
  • Capital returns and balance sheet actions: Increased quarterly dividend (~4.3%), repurchased $24.2 million of shares in Q2, and announced a new $250 million indefinite share repurchase authorization; net debt approx. $721.0 million with net debt / trailing‑12‑month adjusted EBITDA ~2.3x.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.